MCS
CHE icon

Metatron Capital SICAV’s Chemed CHE Stock Holding History

Metatron Capital SICAV’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$952K Buy
+1,800
New +$864K 0.91% 32

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Metatron Capital SICAV's CHE Position: Q4 2021 in Review

Metatron Capital SICAV opened a new position in Chemed (CHE) in Q4 2021: 1,800 shares worth $952K. The stake represents 0.91% of the portfolio and ranks #32 among its holdings.

420 funds tracked by Wall St. Rank hold CHE as of Q4 2021.

  • Metatron Capital SICAV held 1,800 shares of Chemed worth $952K as of Q4 2021.
  • Chemed was a new Metatron Capital SICAV position in Q4 2021.
  • Chemed made up 0.91% of Metatron Capital SICAV's portfolio in Q4 2021, its #32 holding.
  • 420 funds tracked by Wall St. Rank held Chemed as of Q4 2021.

Based on Metatron Capital SICAV's 13F filing for Q4 2021, filed 15 Feb 2022.